Immunomic Therapeutics, Inc. — Form D

Immunomic Therapeutics, Inc. of ROCKVILLE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-10. The offering totals $20.9M, of which $3.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (44)

Showing 25 of 44 people.

NameRoleLocation
Robert ERIC AhlgrenDirectorROCKVILLE, MD
Ki-Hong ERIC AhnDirectorROCKVILLE, MD
Matthew ERIC ChangDirectorROCKVILLE, MD
Yang Gon ERIC JinDirectorROCKVILLE, MD
Michael ERIC LackDirectorROCKVILLE, MD
Steve ERIC ParkDirectorROCKVILLE, MD
Ronald ERIC ThiboutotDirectorROCKVILLE, MD
James ERIC WishartDirectorROCKVILLE, MD
C. ERIC WINZERExecutive OfficerROCKVILLE, MD
Yang Gon JinDirectorROCKVILLE, MD
Steve ParkDirectorROCKVILLE, MD
Robert AhlgrenDirectorROCKVILLE, MD
Dong-Gun KimDirectorROCKVILLE, MD
Dong-Gun KimExecutive OfficerROCKVILLE, MD
James WishartDirectorROCKVILLE, MD
Ki-Hong AhnDirectorROCKVILLE, MD
Matthew ChangDirectorROCKVILLE, MD
C. ERIC WINZERDirectorROCKVILLE, MD
Ronald P ThiboutotDirectorHarrisburg, PA
MICHAEL D LACKDirectorROCKVILLE, MD
ALEX S KIMDirectorROCKVILLE, MD
YANG-GON P JINDirectorROCKVILLE, MD
HYUK JOO P JEEDirectorROCKVILLE, MD
ARLO P MCGINNDirectorROCKVILLE, MD
Bruce F MacklerDirectorOntario, A6

Other filings by this issuer (12)

FiledFormOfferingSold
2025-06-02D$16.0M$6.5M
2021-01-14D/A$77.7M$77.7M
2020-02-26D$60.0M$10.0M
2018-08-03D$315K$315K
2017-03-15D$10.0M$4.6M
2014-10-15D/A$8.8M$6.8M
2014-10-15D/A$8.8M$6.8M
2014-04-24D$8.8M$1.0M
2013-06-12D$3.0M$2.7M
2013-06-12D$1.3M$1.1M
2013-06-12D/A$2.0M$1.6M
2012-03-05D$2.0M$1.1M

More